This phase I open label study is conducted to assess the potential pharmacokinetic
interaction of Raxone® with midazolam in healthy male volunteers
Drug: Raxone (idebenone 150 mg)
Drug: Midazolam 2,5 mg
We will connect you to the doctor responsible for this trial and help you get more information.
Locations near you
Unfortunately, there are no recruiting locations near you. Please check the list with all locations below.
Full eligibility criteria for NCT02887443
Ages eligible for Study
18 Years to 55 Years
Genders eligible for Study
Accepts Healthy Volunteers
Healthy male aged 18 to 55 years.
A Body Mass Index (BMI) of 18-30. BMI = Body weight (kg) / Height (m)2.
Male subject willing to use an acceptable effective contraceptive measure for the entire duration of study participation.
No clinically significant abnormal serum biochemistry, haematology and urine examination values.
A negative urinary test for drugs of abuse and alcohol breath screen. A positive alcohol test may be repeated at the discretion of the Investigator.
Negative HIV and Hepatitis B and C results.
No clinically significant abnormalities in 12 lead electrocardiogram (ECG).
No clinically significant abnormalities in blood pressure, pulse or oral temperature.
No allergy or sensitivity to midazolam, idebenone or any of their excipients.
No current or past medical condition that might significantly affect the pharmacokinetic or pharmacodynamic response to midazolam.
Subject must be available to complete the study (including follow-up visit).
Subject must satisfy a medical examiner about their fitness to participate in the study.
Subject must provide written informed consent to participate in the study.
Covered by Health Insurance System and/or in compliance with the recommendations of National Law in force relating to biomedical research.
A clinically significant history of gastrointestinal disorder likely to influence drug absorption.
Use of any medication (prescription or OTC, including health supplements and herbal remedies, except paracetamol, within 2 weeks or 5 half-lives (whichever is longer) prior to the first dose of trial medication.
Use of any medication known to induce or inhibit any of the enzymes within the CYP3A system within 28 days of Day 1, or grapefruit within 7 days of Day 1
Evidence of renal, hepatic dysfunction, cardiovascular or metabolic dysfunction.
History of obstructive sleep apnoea syndrome.
History of any significant drug allergy including benzodiazepine.
A clinically significant history of drug or alcohol abuse.
Inability to communicate well with the Investigator (i.e., language problem, poor mental development or impaired cerebral function).
Participation in a clinical trial of a New Chemical Entity within the previous 3 months or of a Marketed Product within the previous 30 days (or 5 times the half-life, whichever is longer).
Donation of 450 mL or more blood within the previous 3 months.
Smoking or use of tobacco products or substitutes within the previous 6 months, as determined at the Screening visit.
Need for administrative or legal supervision.
Subject who would receive more than 4500 euros as indemnities for participation in biomedical research within 12 months, including the indemnities for the present study.
All locations for NCT02887443
Gières, France, 38610
View full eligibility
Tris trial is registered with FDA with number: NCT02887443. The sponsor of the trial is Santhera Pharmaceuticals and it is looking for 32 volunteers for the current phase.
Official trial title: An Open-label Study to Assess the Potential for Pre-systemic Inhibition of Cytochrome P450 3A4 (CYP3A) by Idebenone in Healthy Male Subjects Using Midazolam as a Substrate
1What's a trial
4Get in touch
What's a trial
Not sure you're well informed about clinical trials? Learn more about their benefits, risks and other important details.
Enter your details like condition, age, gender and other preferences and we will show you a list of all relevant clinical trials.
Review the summary of the selected clinical trial and all the locations near you in order to see if it's of interest to you.
Get in touch
You've found an interesting trial? We'll need a bit more information about you so we can connect you to the doctor in charge.
Some people want to consult their doctor before considering participation in a clinical trial. This is absolutely normal as your doctor should know your medical history and should be able to advise you. If you want you can easily share the information for this trial with your doctor by clicking on the button below.